Sethu Sankaranarayanan

2.7k citations

38 papers · 1.4k indexed · h-index 21

Physiology top 5%
Molecular Biology
Neurology top 2%
Cellular and Molecular Neuroscience top 5%
Psychiatry and Mental health top 5%

Co-authors: Ted Yednock Adam J. Simon Guoxin Wu Kaj Blennow Henrik Zetterberg Michael K. Ahlijanian Jere E. Meredith Charles F. Albright
Topics: Alzheimer's disease research and treatments (18 papers)Neuroinflammation and Neurodegeneration Mechanisms (7 papers)Dementia and Cognitive Impairment Research (6 papers)
Cited by: Neurology Physiology Biological Psychiatry
Journals: Science Neuron Journal of Neuroscience
Partner nations: United States United Kingdom Sweden

In The Last Decade

Sethu Sankaranarayanan

36 papers receiving 1.4k citations

Peers

Countries citing papers authored by Sethu Sankaranarayanan

Since Specialization

Citations

This map shows the geographic impact of Sethu Sankaranarayanan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sethu Sankaranarayanan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sethu Sankaranarayanan more than expected).

Fields of papers citing papers by Sethu Sankaranarayanan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sethu Sankaranarayanan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sethu Sankaranarayanan. The network helps show where Sethu Sankaranarayanan may publish in the future.

Co-authorship network of co-authors of Sethu Sankaranarayanan

This figure shows the co-authorship network connecting the top 25 collaborators of Sethu Sankaranarayanan. A scholar is included among the top collaborators of Sethu Sankaranarayanan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sethu Sankaranarayanan. Sethu Sankaranarayanan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	CSF d18:1 sphingolipid species in Parkinson disease and dementia with Lewy bodies with and without GBA1 variants 2024 ·npj Parkinson s Disease ·Stefanie Lerche,Isabel Wurster,Enza Maria Valente,Micol Avenali,(unknown),Marta Martínez‐Vicente,Jorge Hernández‐Vara,Ariadna Laguna,Andrea Sturchio,Per Svenningsson,(unknown),Carrolee Barlow,Sethu Sankaranarayanan,Kathrin Brockmann	0
2	Pharmacokinetic and Target Engagement Measures of ANX007, an Anti-C1q Antibody Fragment, Following Intravitreal Administration in Nonhuman Primates 2023 ·Investigative Ophthalmology & Visual Science ·Anita Grover,Sethu Sankaranarayanan,Vidhu Mathur,(unknown),Haiyan Qiu,Yaisa Andrews‐Zwilling,(unknown),(unknown),Ellen Cahir-McFarland,Sanjay C. Keswani,Ted Yednock	8
3	Safety and Target Engagement of Complement C1q Inhibitor ANX007 in Neurodegenerative Eye Disease 2023 ·SHILAP Revista de lepidopterología ·Yang Sun,David Wirta,(unknown),Vidhu Mathur,Sethu Sankaranarayanan,(unknown),Ted Yednock,Donald S. Fong,Jeffrey L. Goldberg	16
4	Inhibiting C1q Improves Compound Muscle Action Potential and Reduces Neuronal Damage in the SOD1G93A Mouse Model (P1-13.004) 2022 ·Neurology ·Yaisa Andrews‐Zwilling,Vidhu Mathur,(unknown),Sethu Sankaranarayanan,Ellen Cahir-McFarland,Ted Yednock	2
5	Complement factor C1q mediates sleep spindle loss and epileptic spikes after mild brain injury 2021 ·Science ·Stephanie S. Holden,Fiorella C. Grandi,(unknown),Bryan Higashikubo,Frances S. Cho,Andrew H. Chang,Alejandro Osorio-Forero,(unknown),Vidhu Mathur,(unknown),(unknown),Sethu Sankaranarayanan,Yaisa Andrews‐Zwilling,Andrea J. Tenner,Anita Lüthi,Eleonora Aronica,M. Ryan Corces,Ted Yednock,Jeanne T. Paz	73
6	Pharmacokinetics and target engagement of intravitreal administration of ANX007, an anti-C1q antibody fragment, in nonhuman primates 2021 ·Investigative Ophthalmology & Visual Science ·Anita Grover,Sethu Sankaranarayanan,Vidhu Mathur,(unknown),Yaisa Andrews‐Zwilling,(unknown),(unknown),Ellen Cahir-McFarland,Sanjay C. Keswani,Ted Yednock	2
7	The Classical Complement Pathway Mediates Microglia-Dependent Remodeling of Spinal Motor Circuits during Development and in SMA 2019 ·Cell Reports ·(unknown),Nicolas Delestrée,Emily V. Fletcher,John G. Pagiazitis,Sethu Sankaranarayanan,Ted Yednock,Ben A. Barres,George Z. Mentis	86
8	C1q-targeted inhibition of the classical complement pathway prevents injury in a novel mouse model of acute motor axonal neuropathy 2016 ·Acta Neuropathologica Communications ·Rhona McGonigal,(unknown),Denggao Yao,Jennifer A. Barrie,Sethu Sankaranarayanan,Simon Ngamli Fewou,Koichi Furukawa,Ted Yednock,Hugh J. Willison	49
9	Centrally Delivered BACE1 Inhibitor Activates Microglia, and Reverses Amyloid Pathology and Cognitive Deficit in Aged Tg2576 Mice 2015 ·Journal of Neuroscience ·Deepak R. Thakker,Sethu Sankaranarayanan,Marcy R. Weatherspoon,(unknown),Maria Pierdomenico,(unknown),Lorin A. Thompson,Roy Haskell,James E. Grace,Sarah Taylor,Charles F. Albright,Lisa Shafer	26
10	Tau Overexpression Impacts a Neuroinflammation Gene Expression Network Perturbed in Alzheimer’s Disease 2014 ·PLoS ONE ·Paul D. Wes,Amy Easton,John Corradi,Donna M. Barten,Nino Devidze,Lynn B. DeCarr,Amy Truong,Aiqing He,Nestor X. Barrezueta,Craig Polson,Clotilde Bourin,(unknown),(unknown),(unknown),Jere E. Meredith,JoAnne E. Natale,Sethu Sankaranarayanan,Greg Cadelina,(unknown),Angela Cacace	84
11	Characterization of Novel CSF Tau and ptau Biomarkers for Alzheimer’s Disease 2013 ·PLoS ONE ·Jere E. Meredith,Sethu Sankaranarayanan,Valerie Guss,Anthony J. Lanzetti,Flora Berisha,Robert Neely,J. Randall Slemmon,Erik Portelius,Henrik Zetterberg,Kaj Blennow,Holly Soares,Michael K. Ahlijanian,Charles F. Albright	152
12	Effects of sub-chronic donepezil on brain Abeta and cognition in a mouse model of Alzheimer’s disease 2013 ·Psychopharmacology ·(unknown),Sethu Sankaranarayanan,(unknown),Dick Terwel,(unknown),Nina Hoque,Clotilde Bourin,Huidong Gu,Michael K. Ahlijanian,Linda J. Bristow	30
13	Pharmacological applications of a novel neoepitope antibody to a modified amyloid precursor protein-derived beta-secretase product 2011 ·Protein & Cell ·Guoxin Wu,Sethu Sankaranarayanan,Donna L. Montgomery,Adam Simon,Zhiqiang An,Mary J. Savage	3
14	Decrease in brain soluble amyloid precursor protein β (sAPPβ) in Alzheimer's disease cortex 2011 ·Journal of Neuroscience Research ·Guoxin Wu,Sethu Sankaranarayanan,(unknown),Adam J. Simon,Mary J. Savage	26
15	Viable mouse gene ablations that robustly alter brain Aβ levels are rare 2010 ·BMC Neuroscience ·Jeremy H. Toyn,(unknown),Mark Thompson,Valerie Guss,Jere E. Meredith,Sethu Sankaranarayanan,Nestor X. Barrezueta,John Corradi,Antara Majumdar,Daniel L. Small,(unknown),Thomas H. Lanthorn,Ryan S. Westphal,Charles F. Albright	8
16	Elevated Cerebrospinal Fluid BACE1 Activity in Incipient Alzheimer Disease 2008 ·Archives of Neurology ·Henrik Zetterberg,Ulf Andréasson,Oskar Hansson,Guoxin Wu,Sethu Sankaranarayanan,Malin E. Andersson,Peder Buchhave,Elisabet Londos,Robert M. Umek,Lennart Minthon,Adam J. Simon,Kaj Blennow	182
17	In Vivo β-Secretase 1 Inhibition Leads to Brain Aβ Lowering and Increased α-Secretase Processing of Amyloid Precursor Protein without Effect on Neuregulin-1 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Sethu Sankaranarayanan,Eric A. Price,Guoxin Wu,Ming‐Chih Crouthamel,Xiao‐Ping Shi,Katherine Tugusheva,(unknown),Jason A. Kahana,Joan D. Ellis,Lixia Jin,Thomas G. Steele,Shawn J. Stachel,Craig A. Coburn,Adam J. Simon	83
18	Strategies toward improving the brain penetration of macrocyclic tertiary carbinamine BACE-1 inhibitors 2007 ·Bioorganic & Medicinal Chemistry Letters ·Keith P. Moore,Hong Zhu,Hemaka A. Rajapakse,Georgia B. McGaughey,Dennis Colussi,Eric A. Price,Sethu Sankaranarayanan,Adam Simon,Nicole T. Pudvah,Jerome Hochman,Timothy J. Allison,Sanjeev Munshi,Samuel Graham,Joseph P. Vacca,Philippe G. Nantermet	29
19	Genetically Modified Mice Models for Alzheimers Disease 2006 ·Current Topics in Medicinal Chemistry ·Sethu Sankaranarayanan	9
20	Regulation of Gene Expression by Lithium and Depletion of Inositol in Slices of Adult Rat Cortex 2005 ·Neuron ·Philip E. Brandish,(unknown),Daniel Holder,Paul Hodor,(unknown),Robert Kleinhanz,(unknown),(unknown),Sven Duenwald,Mark L Parrish,Na Sang,Yuan Liu,Robert L. Phillips,John J. Renger,Sethu Sankaranarayanan,Adam J. Simon,Edward M. Scolnick	69

About Sethu Sankaranarayanan

Sethu Sankaranarayanan is a scholar working on Neurology, Physiology and Psychiatry and Mental health, having authored 38 papers that have together received 1.4k indexed citations. Recurring topics across this work include Alzheimer's disease research and treatments (18 papers), Neuroinflammation and Neurodegeneration Mechanisms (7 papers) and Dementia and Cognitive Impairment Research (6 papers). The work is most often cited by research in Neurology (312 citations), Physiology (764 citations) and Biological Psychiatry (46 citations). Sethu Sankaranarayanan has collaborated with scholars based in United States, United Kingdom and Sweden. Frequent co-authors include Ted Yednock, Adam J. Simon, Guoxin Wu, Kaj Blennow, Henrik Zetterberg, Michael K. Ahlijanian, Jere E. Meredith, Charles F. Albright, Valerie Guss and Haiyan Qiu. Their work appears in journals such as Science, Neuron and Journal of Neuroscience.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact